Allianz Asset Management Gmb H Harmony Biosciences Holdings, Inc. Transaction History

Allianz Asset Management Gmb H

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$30.5 - $37.4 $225,700 - $276,760	-7,400 Reduced 23.72%	23,800 $837,000
Q1 2023 May 11, 2023	BUY	$30.8 - $53.92 $372,680 - $652,432	12,100 Added 63.35%	31,200 $1.02 Million
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $867,140 - $1.16 Million	19,100 New	19,100 $1.05 Million

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.04B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.